{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:47:14Z","timestamp":1782456434466,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Severe traumatic brain injury (TBI) is associated with high mortality and long-term disability. Inflammation is central to TBI pathophysiology, yet early dynamics of inflammatory mediators in blood and cerebrospinal fluid (CSF) remain incompletely understood, and commonly used assay platforms have rarely been directly compared. We aimed to characterize the inflammatory response in blood and CSF during the first week after severe TBI and to assess agreement between electrochemiluminescence (ECL) and proximity extension assay (PEA). In this prospective observational study, adults with severe TBI (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200921) were recruited. Plasma and CSF samples were collected at two time points: days 1\u20133 and days 4\u20138. Orthopedic patients with minor extremity fractures (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200911) served as controls. Inflammatory mediator levels were quantified using ECL (11 mediators) and PEA (45 mediators). Group differences, temporal changes, and inter-platform agreement were analyzed. In plasma, 13 mediators were increased and 3 decreased, while in CSF, 19 were increased and 3 decreased during the first week post-injury. Key mediators (IL-6, IL-8, IL-10) were consistently elevated in both compartments. When comparing analytic methods, ECL and PEA showed strong cross-platform correlations for IL-8 and IL-10 in both plasma and CSF, whereas IL-13 showed weak, non-significant correlation. However, limited interchangeability between platforms and platform-related differences across compartments and time points were also observed. Severe TBI is associated with marked, temporal and compartmentalized inflammatory response during first post-injury, particularly in CSF. Comparison of ECL and PEA showed limited interchangeability, underscoring the importance of platform awareness and interpretation in TBI biomarker studies. Clinical trial number: Not applicable.\n                  <\/jats:p>","DOI":"10.1007\/s10753-026-02549-9","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:33:23Z","timestamp":1782452003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis"],"prefix":"10.1007","volume":"49","author":[{"given":"Oskar W.","family":"Persson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Ruscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Uvelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-5626","authenticated-orcid":false,"given":"Niklas","family":"Marklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"1","key":"2549_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","volume":"18","author":"SL James","year":"2019","unstructured":"James, S. L., A. Theadom, R. G. Ellenbogen, M. S. Bannick, W. Montjoy-Venning, and L. R. Lucchesi et al. 2019. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 18(1):56\u201387.","journal-title":"The Lancet Neurology"},{"issue":"2","key":"2549_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.pmr.2016.12.001","volume":"28","author":"KJ Dixon","year":"2017","unstructured":"Dixon, K. J. 2017. Pathophysiology of Traumatic Brain Injury. Physical Medicine and Rehabilitation Clinics of North America 28(2):215\u2013225.","journal-title":"Physical Medicine and Rehabilitation Clinics of North America"},{"key":"2549_CR3","doi-asserted-by":"publisher","first-page":"102665","DOI":"10.1016\/j.nicl.2021.102665","volume":"30","author":"N Marklund","year":"2021","unstructured":"Marklund, N., F. Vedung, M. Lubberink, Y. Tegner, J. Johansson, and K. Blennow et al. 2021. Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients - A PET\/MR study. Neuroimage Clin 30:102665.","journal-title":"Neuroimage Clin"},{"issue":"3","key":"2549_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon, D. W., M. J. McGeachy, H. Bay\u0131r, R. S. Clark, D. J. Loane, and P. M. Kochanek. 2017. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol 13(3):171\u2013191.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2549_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/brain\/awae305","volume":"148","author":"LM Li","year":"2025","unstructured":"Li, L. M., E. Kodosaki, A. Heslegrave, H. Zetterberg, N. Graham, and K. Zimmerman et al. 2025. High-dimensional proteomic analysis for pathophysiological classification of traumatic brain injury. Brain 148(3):1015\u20131030.","journal-title":"Brain"},{"key":"2549_CR6","doi-asserted-by":"publisher","first-page":"105310","DOI":"10.1016\/j.ebiom.2024.105310","volume":"108","author":"RJ Samanta","year":"2024","unstructured":"Samanta, R. J., A. C. Chiollaz, E. Needham, J. K. Yue, A. Helmy, and E. R. Zanier et al. 2024. Parsimonious immune-response endotypes and global outcome in patients with traumatic brain injury. EBioMedicine 108:105310.","journal-title":"EBioMedicine"},{"key":"2549_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2016.06.009","volume":"149","author":"EL Nwachuku","year":"2016","unstructured":"Nwachuku, E. L., A. M. Puccio, A. Adeboye, Y-F. Chang, J. Kim, and D. O. Okonkwo. 2016. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury. Clinical Neurology and Neurosurgery 149:1\u20135.","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"11","key":"2549_CR8","doi-asserted-by":"publisher","first-page":"113395","DOI":"10.1016\/j.celrep.2023.113395","volume":"42","author":"R Garza","year":"2023","unstructured":"Garza, R., Y. Sharma, D. A. M. Atacho, A. Thiruvalluvan, S. Abu Hamdeh, and M. E. J\u00f6nsson et al. 2023. Single-cell transcriptomics of human traumatic brain injury reveals activation of endogenous retroviruses in oligodendroglia. Cell Rep 42(11):113395.","journal-title":"Cell Rep"},{"key":"2549_CR9","doi-asserted-by":"crossref","unstructured":"Yoo, S. M., Y. M. Jeon, and S. Y. Heo. 2022. Electrochemiluminescence systems for the detection of biomarkers: strategical and technological advances. Biosensors.. 2022;12(9):738","DOI":"10.3390\/bios12090738"},{"issue":"1","key":"2549_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12974-023-02864-0","volume":"20","author":"A Gard","year":"2023","unstructured":"Gard, A., F. Vedung, F. Piehl, M. Khademi, M. P. Wernersson, and I. Rorsman et al. 2023. Cerebrospinal fluid levels of neuroinflammatory biomarkers are increased in athletes with persistent post-concussive symptoms following sports-related concussion. Journal of Neuroinflammation 20(1):189.","journal-title":"Journal of Neuroinflammation"},{"key":"2549_CR11","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik, L., N. Nordberg, J. Broberg, J. Bj\u00f6rkesten, E. Assarsson, and S. Henriksson et al. 2021. Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis. Molecular & Cellular Proteomics 20:100168.","journal-title":"Molecular & Cellular Proteomics"},{"issue":"7","key":"2549_CR12","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.4049\/jimmunol.2300729","volume":"212","author":"K Abe","year":"2024","unstructured":"Abe, K., J. C. Beer, T. Nguyen, I. S. Ariyapala, T. H. Holmes, and W. Feng et al. 2024. Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort. The Journal of Immunology 212(7):1244\u20131253.","journal-title":"The Journal of Immunology"},{"key":"2549_CR13","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.cpnec.2021.100052","volume":"7","author":"J Herbers","year":"2021","unstructured":"Herbers, J., R. Miller, A. Walther, L. Schindler, K. Schmidt, and W. Gao et al. 2021. How to deal with non-detectable and outlying values in biomarker research: Best practices and recommendations for univariate imputation approaches. Compr Psychoneuroendocrinol 7:100052.","journal-title":"Compr Psychoneuroendocrinol"},{"key":"2549_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2019.04.005","volume":"332","author":"EJ Needham","year":"2019","unstructured":"Needham, E. J., A. Helmy, E. R. Zanier, J. L. Jones, A. J. Coles, and D. K. Menon. 2019. The immunological response to traumatic brain injury. Journal Of Neuroimmunology 332:112\u2013125.","journal-title":"Journal Of Neuroimmunology"},{"issue":"11","key":"2549_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","volume":"21","author":"AIR Maas","year":"2022","unstructured":"Maas, A. I. R., D. K. Menon, G. T. Manley, M. Abrams, C. \u00c5kerlund, and N. Andelic et al. 2022. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurology 21(11):1004\u20131060.","journal-title":"Lancet Neurology"},{"issue":"2","key":"2549_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/neu.2017.5155","volume":"35","author":"EP Thelin","year":"2018","unstructured":"Thelin, E. P., C. E. Hall, K. Gupta, K. L. H. Carpenter, S. Chandran, and P. J. Hutchinson et al. 2018. Elucidating Pro-Inflammatory Cytokine Responses after Traumatic Brain Injury in a Human Stem Cell Model. Journal Of Neurotrauma 35(2):341\u2013352.","journal-title":"Journal Of Neurotrauma"},{"issue":"1","key":"2549_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/neur.2022.0067","volume":"4","author":"P Dyhrfort","year":"2023","unstructured":"Dyhrfort, P., T. S. Wettervik, F. Clausen, P. Enblad, L. Hillered, and A. Lew\u00e9n. 2023. A Dedicated 21-Plex Proximity Extension Assay Panel for High-Sensitivity Protein Biomarker Detection Using Microdialysis in Severe Traumatic Brain Injury: The Next Step in Precision Medicine? Neurotrauma Reports 4(1):25\u201340.","journal-title":"Neurotrauma Reports"},{"issue":"2","key":"2549_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/jcbfm.2010.142","volume":"31","author":"A Helmy","year":"2011","unstructured":"Helmy, A., K. L. Carpenter, D. K. Menon, J. D. Pickard, and P. J. Hutchinson. 2011. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. Journal Of Cerebral Blood Flow And Metabolism 31(2):658\u2013670.","journal-title":"Journal Of Cerebral Blood Flow And Metabolism"},{"issue":"3","key":"2549_CR19","first-page":"137","volume":"21","author":"Y Xiong","year":"2018","unstructured":"Xiong, Y., A. Mahmood, and M. Chopp. 2018. Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chinese Journal Of Traumatology = Zhonghua Chuang Shang Za Zhi \/ Chinese Medical Association 21(3):137\u2013151.","journal-title":"Chinese Journal Of Traumatology = Zhonghua Chuang Shang Za Zhi \/ Chinese Medical Association"},{"issue":"8","key":"2549_CR20","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1177\/0271678X15620204","volume":"36","author":"A Helmy","year":"2016","unstructured":"Helmy, A., M. R. Guilfoyle, K. L. H. Carpenter, J. D. Pickard, D. K. Menon, and P. J. Hutchinson. 2016. Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury. Journal Of Cerebral Blood Flow And Metabolism 36(8):1434\u20131448.","journal-title":"Journal Of Cerebral Blood Flow And Metabolism"},{"issue":"1","key":"2549_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuron.2015.05.019","volume":"87","author":"SP Gadani","year":"2015","unstructured":"Gadani, S. P., J. T. Walsh, J. R. Lukens, and J. Kipnis. 2015. Dealing with Danger in the CNS: The Response of the Immune System to Injury. Neuron 87(1):47\u201362.","journal-title":"Neuron"},{"issue":"4","key":"2549_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12975-011-0125-x","volume":"2","author":"A Chodobski","year":"2011","unstructured":"Chodobski, A., B. J. Zink, and J. Szmydynger-Chodobska. 2011. Blood-brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res 2(4):492\u2013516.","journal-title":"Transl Stroke Res"},{"key":"2549_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fneur.2015.00235","volume":"6","author":"J Hazeldine","year":"2015","unstructured":"Hazeldine, J., J. M. Lord, and A. Belli. 2015. Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus. Frontiers In Neurology 6:235.","journal-title":"Frontiers In Neurology"},{"issue":"1","key":"2549_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13054-021-03698-z","volume":"25","author":"CA Santacruz","year":"2021","unstructured":"Santacruz, C. A., J-L. Vincent, A. Bader, L. A. Rinc\u00f3n-Guti\u00e9rrez, C. Dominguez-Curell, and D. Communi et al. 2021. Association of cerebrospinal fluid protein biomarkers with outcomes in patients with traumatic and non-traumatic acute brain injury: systematic review of the literature. Critical Care 25(1):278.","journal-title":"Critical Care"},{"issue":"1","key":"2549_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12987-022-00405-0","volume":"20","author":"N Rostgaard","year":"2023","unstructured":"Rostgaard, N., M. H. Olsen, M. Ottenheijm, L. Drici, A. H. Simonsen, and P. Plomgaard et al. 2023. Differential proteomic profile of lumbar and ventricular cerebrospinal fluid. Fluids and Barriers of the CNS 20(1):6.","journal-title":"Fluids and Barriers of the CNS"},{"issue":"7","key":"2549_CR26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/jor.25183","volume":"40","author":"A Aneja","year":"2022","unstructured":"Aneja, A., D. C. Landy, P. N. Mittwede, A. Y. Albano, R. J. Teasdall, and A. Isla et al. 2022. Inflammatory cytokines associated with outcomes in orthopedic trauma patients independent of New Injury Severity score: A pilot prospective cohort study. Journal Of Orthopaedic Research 40(7):1555\u20131562.","journal-title":"Journal Of Orthopaedic Research"},{"issue":"1","key":"2549_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13054-021-03503-x","volume":"25","author":"C Lindblad","year":"2021","unstructured":"Lindblad, C., E. Pin, D. Just, F. Al Nimer, P. Nilsson, and B-M. Bellander et al. 2021. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood\u2013brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study. Critical Care 25(1):103.","journal-title":"Critical Care"},{"key":"2549_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fneur.2017.00300","volume":"8","author":"EP Thelin","year":"2017","unstructured":"Thelin, E. P., F. A. Zeiler, A. Ercole, S. Mondello, A. B\u00fcki, and B. M. Bellander et al. 2017. Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review. Frontiers In Neurology 8:300.","journal-title":"Frontiers In Neurology"},{"issue":"1","key":"2549_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12974-022-02654-0","volume":"19","author":"SR Shultz","year":"2022","unstructured":"Shultz, S. R., A. D. Shah, C. Huang, L. K. Dill, R. B. Schittenhelm, and M. C. Morganti-Kossmann et al. 2022. Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury. Journal of Neuroinflammation 19(1):291.","journal-title":"Journal of Neuroinflammation"},{"key":"2549_CR30","doi-asserted-by":"publisher","first-page":"1013933","DOI":"10.3389\/fnmol.2022.1013933","volume":"15","author":"J Yang","year":"2022","unstructured":"Yang, J., M. Ran, H. Li, Y. Lin, K. Ma, and Y. Yang et al. 2022. New insight into neurological degeneration: Inflammatory cytokines and blood-brain barrier. Frontiers In Molecular Neuroscience 15:1013933.","journal-title":"Frontiers In Molecular Neuroscience"},{"key":"2549_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroscience.2013.11.036","volume":"266","author":"X Chen","year":"2014","unstructured":"Chen, X., X. S. Duan, L. J. Xu, J. J. Zhao, Z. F. She, and W. W. Chen et al. 2014. Interleukin-10 mediates the neuroprotection of hyperbaric oxygen therapy against traumatic brain injury in mice. Neuroscience 266:235\u2013243.","journal-title":"Neuroscience"},{"issue":"6","key":"2549_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/HTR.0000000000000067","volume":"30","author":"RG Kumar","year":"2015","unstructured":"Kumar, R. G., J. A. Boles, and A. K. Wagner. 2015. Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury. The Journal Of Head Trauma Rehabilitation 30(6):369\u2013381.","journal-title":"The Journal Of Head Trauma Rehabilitation"},{"issue":"3","key":"2549_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3171\/2015.6.JNS15674","volume":"125","author":"A Raheja","year":"2016","unstructured":"Raheja, A., S. Sinha, N. Samson, S. Bhoi, A. Subramanian, and P. Sharma et al. 2016. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial. Case Report Journal Of Neurosurgery 125(3):631\u2013641.","journal-title":"Case Report Journal Of Neurosurgery"},{"key":"2549_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fneur.2017.00331","volume":"8","author":"FA Zeiler","year":"2017","unstructured":"Zeiler, F. A., E. P. Thelin, M. Czosnyka, P. J. Hutchinson, D. K. Menon, and A. Helmy. 2017. Cerebrospinal Fluid and Microdialysis Cytokines in Severe Traumatic Brain Injury: A Scoping Systematic Review. Frontiers In Neurology 8:331.","journal-title":"Frontiers In Neurology"},{"issue":"15","key":"2549_CR35","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.1073\/pnas.96.15.8721","volume":"96","author":"U Scherbel","year":"1999","unstructured":"Scherbel, U., R. Raghupathi, M. Nakamura, K. E. Saatman, J. Q. Trojanowski, and E. Neugebauer et al. 1999. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci U S A 96(15):8721\u20138726.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2549_CR36","first-page":"427","volume":"21","author":"K Strle","year":"2001","unstructured":"Strle, K., J. H. Zhou, W. H. Shen, S. R. Broussard, R. W. Johnson, and G. G. Freund et al. 2001. Interleukin-10 in the brain. Critical Reviews In Immunology 21(5):427\u2013449.","journal-title":"Critical Reviews In Immunology"},{"issue":"1","key":"2549_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12974-016-0500-3","volume":"13","author":"AP Di Battista","year":"2016","unstructured":"Di Battista, A. P., S. G. Rhind, M. G. Hutchison, S. Hassan, M. Y. Shiu, and K. Inaba et al. 2016. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. Journal of Neuroinflammation 13(1):40.","journal-title":"Journal of Neuroinflammation"},{"key":"2549_CR38","doi-asserted-by":"publisher","first-page":"113473","DOI":"10.1016\/j.jim.2023.113473","volume":"517","author":"HL Zetlen","year":"2023","unstructured":"Zetlen, H. L., K. T. Cao, K. D. Schichlein, N. Knight, H. T. Maecker, and K. C. Nadeau et al. 2023. Comparison of multiplexed protein analysis platforms for the detection of biomarkers in the nasal epithelial lining fluid of healthy subjects. Journal of Immunological Methods 517:113473.","journal-title":"Journal of Immunological Methods"},{"issue":"1","key":"2549_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/17576180.2024.2442190","volume":"17","author":"K McKinski","year":"2025","unstructured":"McKinski, K., H. Tang, K. Wang, M. Birchler, and M. Wright. 2025. Comparison of highly sensitive, multiplex immunoassay platforms for streamlined clinical cytokine quantification. Bioanalysis 17(1):17\u201329.","journal-title":"Bioanalysis"},{"issue":"1","key":"2549_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12974-021-02264-2","volume":"18","author":"P Lassar\u00e9n","year":"2021","unstructured":"Lassar\u00e9n, P., C. Lindblad, A. Frostell, K. L. H. Carpenter, M. R. Guilfoyle, and P. J. A. Hutchinson et al. 2021. Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury. Journal of Neuroinflammation 18(1):221.","journal-title":"Journal of Neuroinflammation"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02549-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02549-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02549-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:08:25Z","timestamp":1782454105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02549-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02549-9","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish Ethical Review Authority (Dnr 2017\/4069; 2017\/1049; Dnr 2022-07096-02). All collected samples were stored in a local biobank (# BD27).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Patients were pseudonymized once samples were collected. Since all patients had a reduced level of consciousness and, thus, were unable to provide consent, informed consent was obtained from patient\u00b4s next of kin. Written informed consent was obtained, prior to the collection of CSF and blood samples, from all controls after provided written and oral information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}